Recommendations for preclinical research in hemorrhagic transformation

Susan C Fagan1, Paul A Lapchak, David S Liebeskind

  • 1Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA ; Charlie Norwood VA Medical Center, Augusta, GA ; Department of Neurology, Medical College of Georgia, Augusta, GA.

Summary

Hemorrhagic transformation (HT) is a major complication after ischemic stroke, often linked to reperfusion therapy. This review outlines research models, clinical factors, and variables influencing HT quantitation, offering recommendations for future preclinical studies.

Related Concept Videos